Search results
Results from the WOW.Com Content Network
Rival McKesson recently acquired a unit of Florida Cancer Specialists & Research Institute for $2.49 billion, while Cencora, in partnership with TPG Inc., purchased OneOncology for $2.1 billion in ...
Upon the close of the transaction, Florida Cancer Specialists — which operates in nearly 100 locations across Florida, with more than 250 physicians and 280 nurses and physician assistants ...
Carrie Cherkinsky, 41, of Tallahassee, Florida, learned of the shortage from a Facebook support group for women with ovarian cancer. Even so, she was shocked to learn that she wouldn’t be able ...
SCRI accrued more than 2,500 patients to cancer trials in 2009, including more than 500 to Phase I investigational studies. [4] Non-oncology trials accounted for nearly 1,500 additional patients for a total of almost 4,000. [5] Its drug development program has conducted 400+ "first-in-human" trials. [6]
UF Health Shands Cancer Hospital is an academic cancer center in Gainesville, Florida. The 200 bed complex focuses on producing basic laboratory findings that will ultimately be used for preventive therapies for cancers .
Cancer Treatment Centers of America (CTCA) was founded in 1988 by Richard J. Stephenson following the death of his mother, Mary Brown Stephenson, who died from lung cancer. [3] Stephenson purchased the American International Hospital in Zion, Illinois , in 1988 and expanded the hospital to include a radiation center, the Mary Brown Stephenson ...
Vincristine, also known as leurocristine and marketed under the brand name Oncovin among others, is a chemotherapy medication used to treat a number of types of cancer. [5] This includes acute lymphocytic leukemia, acute myeloid leukemia, Hodgkin's disease, neuroblastoma, and small cell lung cancer among others. [5] It is given intravenously. [5]
Lori D. Kidd, manager of Memorial Cancer Institute’s Center for Body Mind & Spirit shows accessories during the grand opening of the center, which offers a variety of spa services to cancer ...